Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. GeneDx Holdings Corp shares valued at $3,007,997 were purchased by Meister Keith A. on May 14 ’25. At $60.16 per share, Meister Keith A. acquired 50,000 shares. The insider’s holdings grew to 3,058,629 shares worth approximately $205.94 million following the completion of this transaction.
Also, Meister Keith A. purchased 100,000 shares, netting a total of over 5,600,994 in proceeds. Following the buying of shares at $56.01 each, the insider now holds 3,008,629 shares.
Before that, Feeley Kevin had sold 388 shares from its account. In a trade valued at $43,879, the CHIEF FINANCIAL OFFICER traded GeneDx Holdings Corp shares for $113.09 each. Upon closing the transaction, the insider’s holdings decreased to 388 shares, worth approximately $0.22 million.
As published in their initiating research note from Guggenheim on May 15, 2025, GeneDx Holdings Corp [WGS] has been a Buy and the price target has been revised to $88. Analysts at Jefferies upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early May. As of August 28, 2024, Wells Fargo has initiated its “an Equal weight” rating for WGS. Earlier on July 10, 2024, Craig Hallum initiated its rating. Their recommendation was “a Buy” for WGS stock.
Analyzing WGS Stock Performance
During the last five days, there has been a surge of approximately 5.85%. Over the course of the year, GeneDx Holdings Corp shares have dropped approximately -12.40%. Shares of the company reached a 52-week high of $117.75 on 04/29/25 and a 52-week low of $55.17 on 05/08/25.
Support And Resistance Levels for GeneDx Holdings Corp (WGS)
According to the 24-hour chart, there is a support level at 66.42, which, if violated, would cause prices to drop to 65.50. In the upper region, resistance lies at 68.83. The next price resistance is at 70.32. RSI (Relative Strength Index) is 43.21 on the 14-day chart, showing neutral technical sentiment.
